GLP-1 Trials Expand to Address Alcohol and Drug Cravings | Retatrutide News

GLP-1 receptor agonists are being tested in trials to reduce alcohol and drug cravings. This expansion could broaden their therapeutic use beyond obesit...
Clinical Trials · October 23, 2026